Abstract | OBJECTIVE: RESEARCH DESIGN AND METHODS: In the first part of this study, 10 healthy subjects underwent hyperinsulinemic euglycemic (4.5 mmol/liter) clamps for 6 h with iv infusion of either saline or a 20% Intralipid emulsion (Fresenius Kabi AG, Bad Homburg, Germany). Skeletal muscle biopsies were taken before and after 3- and 6-h insulin infusion and analyzed for calpain-10 mRNA and protein expression. In the second part of the study, muscle samples obtained after an overnight fast in 10 long-standing, sedentary type 2 diabetes patients, 10 sedentary, weight-matched, normoglycemic controls, and 10 age-matched, endurance-trained cyclists were analyzed for calpain-10 mRNA and protein content. RESULTS:
Intralipid infusion in healthy subjects reduced whole body glucose disposal by approximately 50% (P<0.001). Calpain-10 mRNA (P=0.01) but not protein content was reduced after 6-h insulin infusion in both the saline and Intralipid emulsion trials. Skeletal muscle calpain-10 mRNA and protein content did not differ between the type 2 diabetes patients and normoglycemic controls, but there was a strong trend for total calpain-10 protein to be greater in the endurance-trained athletes (P=0.06). CONCLUSIONS: These data indicate that skeletal muscle calpain-10 expression is not modified by insulin resistance per se and suggest that hyperinsulinemia and exercise training may modulate human skeletal muscle calpain-10 expression.
|
Authors | L Norton, T Parr, K Chokkalingam, R G Bardsley, H Ye, G I Bell, M M A L Pelsers, L J C van Loon, K Tsintzas |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 93
Issue 3
Pg. 992-8
(Mar 2008)
ISSN: 0021-972X [Print] United States |
PMID | 18089694
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fat Emulsions, Intravenous
- Glucose Transporter Type 4
- Insulin
- RNA, Messenger
- SLC2A4 protein, human
- Calpain
- calpain 10
|
Topics |
- Adult
- Calpain
(analysis, genetics)
- Diabetes Mellitus, Type 2
(metabolism)
- Fat Emulsions, Intravenous
(pharmacology)
- Glucose Transporter Type 4
(physiology)
- Humans
- Insulin
(blood)
- Insulin Resistance
- Male
- Middle Aged
- Muscle, Skeletal
(chemistry, metabolism)
- RNA, Messenger
(analysis)
|